NeuroLumen Email Formats

Biotechnology Research • San Diego, California, United States • 1-10 Employees

Key Contact at NeuroLumen

Nick Afanasiev

Founder & Vision Lead

Company overview

Headquarters	San Diego, California, United States
Website	neurolumen.bio
NAICS	541714
Keywords	Neuroscience, Biotechnology Research, Brain Health, Regulatory Strategy, Clinical Trial Design, Mental Health Treatment, Psychedelic Science, Addiction Treatment Innovation, Fda Drug Development, Methamphetamine Use Disorder (Mud), Psilocybin-Assisted Psychotherapy
Founded	2025
Employees	1-10

About NeuroLumen

NeuroLumen Bio is an emerging biotechnology company developing the first FDA-approved psilocybin-assisted psychotherapy for methamphetamine use disorder (MUD). MUD affects approximately one million Americans and tens of millions worldwide, yet no medical treatment exists today. Our mission is to combine cutting-edge neuroscience, clinical research, and ethical innovation to bring hope, healing, and effective treatment to people struggling with methamphetamine addiction.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

NeuroLumen has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

NeuroLumen has never raised funding before.

Frequently asked questions

NeuroLumen is located in San Diego, California, US.

NeuroLumen was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

NeuroLumen has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at NeuroLumen

Nick Afanasiev

Founder & Vision Lead

4.8

40,000 users